Analysis on access to antiretroviral therapy for patients with different income and educational level, and the effect of treatment on quality of life after two to three months of therapy

Simple item page
dc.contributor.advisorVan Huyssteen, Mea
dc.contributor.authorMokobori, Mpato
dc.date.accessioned2018-01-17T14:15:15Z
dc.date.accessioned2024-05-15T07:42:51Z
dc.date.available2018-01-17T14:15:15Z
dc.date.available2024-05-15T07:42:51Z
dc.date.issued2017
dc.descriptionMagister Pharmaceuticae - MPharmen_US
dc.description.abstractAccess to antiretroviral therapy (ART) for HIV positive patients has brought hope and a chance to a healthier longer life with improved quality of life (QoL). In this study we explored the difference in health related quality of life (HRQoL) between participants eligible for ART and those not yet eligible for ART as per the 2015 South African HIV treatment guidelines. We also considered the impact of ART access on HRQoL and the effect of employment status and education level. The study was conducted at one tertiary hospital and two primary health care facilities in Johannesburg, South Africa.en_US
dc.identifier.urihttps://hdl.handle.net/10566/15148
dc.language.isoenen_US
dc.publisherUniversity of the Western capeen_US
dc.rights.holderUniversity of the Western Capeen_US
dc.subjectAntiretroviral therapyen_US
dc.subjectEconomic conditionsen_US
dc.subjectIncomeen_US
dc.subjectEducationen_US
dc.subjectQuality of lifeen_US
dc.subjectHIV treatmenten_US
dc.titleAnalysis on access to antiretroviral therapy for patients with different income and educational level, and the effect of treatment on quality of life after two to three months of therapyen_US

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Mokobori_mpharm_nsc_2017.pdf
Size:
7.01 MB
Format:
Adobe Portable Document Format
Download

Collections

Magister Pharmaceuticae - MPharm